CCDC 37, Hôpital Bretonneau, 2 Boulevard Tonnellé, 37044, Tours Cedex 9, France.
INSERM U1193, Département d'Oncologie Médicale, Hôpital Paul Brousse, 12 Avenue Paul Vaillant Couturier, 94800, Villejuif, France.
Curr Oncol Rep. 2018 Mar 5;20(Suppl 1):16. doi: 10.1007/s11912-017-0648-8.
The aim of EDIFICE surveys is to improve insight into the behavior of the French population with regard to cancer prevention and participation in screening programs. Via the colorectal cancer screening program, all average-risk individuals in the 50-74-year age group are invited every 2 years to do a guaiac-based or, since April 2015, an immunochemical fecal occult blood test.
The fifth edition of the nationwide observational survey was conducted by phone interviews using the quota method. A representative sample of 1299 individuals with no history of cancer (age, 50-74 years) was interviewed between 22 November and 7 December 2016. The present analysis focuses on minimum lifetime uptake of screening tests, compliance to recommended repeat-screening intervals, and reasons for non-participation.
In 2016, 64% survey participants had been screened at least once and 38% had been screened in the previous 2 years, suggesting a trend towards increasing participation rates, particularly in the younger age categories and among men. The 2016 data also suggest that the newly implemented FIT-based screening program has been well perceived by the population. Up to one in four individuals cited "no risk factors" as the reason for not undergoing screening. This reveals ignorance of the fact that the colorectal cancer screening program actually targets all average-risk individuals in a given age group, without individual risk factors.
We suggest the next step should be dedicated to educational approaches to explain exactly what screening involves and to persuasive messages targeting those who to date have remained unreceptive to information campaigns.
EDIFICE 调查的目的是提高对法国民众在癌症预防和参与筛查计划方面行为的了解。通过结直肠癌筛查计划,所有年龄在 50-74 岁的普通风险人群每两年都会被邀请进行一次愈创木脂或免疫化学粪便潜血试验。
第五次全国观察性调查通过电话访谈和配额法进行。2016 年 11 月 22 日至 12 月 7 日期间,对 1299 名无癌症病史的(年龄在 50-74 岁之间)代表性个体进行了访谈。本分析重点关注最低终生筛查测试接受率、对推荐的重复筛查间隔的依从性以及不参与的原因。
2016 年,64%的调查参与者至少接受过一次筛查,38%的参与者在过去 2 年内接受过筛查,这表明参与率呈上升趋势,特别是在年轻年龄段和男性中。2016 年的数据还表明,新实施的 FIT 筛查计划得到了民众的良好认可。四分之一的人将“没有风险因素”作为未接受筛查的原因。这表明人们不知道结直肠癌筛查计划实际上针对的是特定年龄组的所有普通风险人群,而不考虑个体风险因素。
我们建议下一步应该致力于开展教育活动,解释筛查的具体内容,并针对那些迄今对宣传活动持抵制态度的人,开展有说服力的信息宣传。